Jiangsu Recbio Technology Co., Ltd. (02179) reported that, as of January 31, 2026, the total authorized share capital remained at RMB 626,075,702. This comprises 297,937,013 Domestic Shares, 12,000,000 Unlisted Foreign Shares, and 316,138,689 H Shares, each with a par value of RMB 1.

In terms of issued shares, there were no changes during the month. Issued Domestic Shares remained at 297,937,013, Unlisted Foreign Shares at 12,000,000, and H Shares at 316,138,689. No treasury shares were recorded.

The company confirmed that its public float is in compliance with the applicable requirements under the listing rules. There were no share options, warrants, convertibles, or other arrangements leading to changes in the company’s share capital during the reporting period.